Lineage Cell Therapeutics In shares owned by DCF Advisers
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by DCF Advisers
from 13F filings
Historical chart of DCF Advisers investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by DCF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $54k | 108k | 0.50 |
| 2024-09-30 | $98k | 108k | 0.91 |
| 2024-06-30 | $108k | 108k | 1.00 |
| 2024-03-31 | $160k | 108k | 1.48 |
| 2023-09-30 | $98k | 83k | 1.18 |
| 2023-06-30 | $21k | 15k | 1.41 |
| 2022-03-31 | $82k | 53k | 1.55 |
| 2021-12-31 | $208k | 85k | 2.45 |
| 2021-09-30 | $219k | 87k | 2.52 |
| 2021-06-30 | $212k | 75k | 2.85 |
| 2021-03-31 | $49k | 21k | 2.33 |